Search

everythinglearnresearchcommunity

for

Search:↓

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Menopausal hormone therapy can improve skin and hair health in menopausal women.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Including androgens in hormone therapy may lower breast cancer risk.

Korean medicinal herbs in hair tonic and food increased hair growth in mice.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Educators and publishers should focus on teaching racism as the cause of health inequity and ensure fair use of race in materials.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Quercetin delivery systems are improving its effectiveness for medical use.

Composite biomaterials can precisely control immune responses for better disease treatment.

Balancing hormones can help women feel youthful and healthy.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

The guideline offers recommendations for diagnosing and managing PCOS and its complications.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Microneedle therapy combined with Hwangryeonhaedoktang solution improved hair growth in mice better than microneedle therapy alone.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

Careful diagnosis and management of MCTD are crucial due to potential severe complications.